Wealthfront Advisers’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1M Sell
5,774
-323
-5% -$66.2K ﹤0.01% 717
2025
Q4
$1.56M Buy
6,097
+635
+12% +$166K ﹤0.01% 631
2025
Q3
$1.42M Sell
5,462
-794
-13% -$209K ﹤0.01% 641
2025
Q2
$1.53M Sell
6,256
-6,640
-51% -$1.66M ﹤0.01% 610
2025
Q1
$3.41M Sell
12,896
-7,184
-36% -$1.94M 0.01% 426
2024
Q4
$5.09M Buy
20,080
+6,465
+47% +$1.73M 0.01% 325
2024
Q3
$4.31M Buy
13,615
+1,581
+13% +$563K 0.01% 336
2024
Q2
$4.5M Sell
12,034
-1,472
-11% -$497K 0.02% 299
2024
Q1
$4.68M Buy
13,506
+903
+7% +$342K 0.02% 283
2023
Q4
$5.77M Buy
12,603
+2,771
+28% +$1.37M 0.02% 214
2023
Q3
$4.78M Buy
9,832
+490
+5% +$230K 0.02% 221
2023
Q2
$4.18M Sell
9,342
-658
-7% -$331K 0.02% 255
2023
Q1
$4.85M Sell
10,000
-4,431
-31% -$2.19M 0.02% 209
2022
Q4
$7.39M Buy
14,431
+7,078
+96% +$3.72M 0.04% 148
2022
Q3
$3.57M Buy
7,353
+363
+5% +$177K 0.02% 241
2022
Q2
$3.27M Buy
6,990
+1,006
+17% +$448K 0.02% 269
2022
Q1
$2.6M Buy
5,984
+758
+15% +$317K 0.01% 340
2021
Q4
$2.42M Buy
5,226
+478
+10% +$212K 0.01% 345
2021
Q3
$1.85M Buy
4,748
+17
+0.4% +$7.22K 0.01% 365
2021
Q2
$2.1M Buy
4,731
+336
+8% +$147K 0.01% 293
2021
Q1
$1.84M Buy
4,395
+337
+8% +$135K 0.01% 291
2020
Q4
$1.67M Sell
4,058
-377
-9% -$157K 0.01% 266
2020
Q3
$1.84M Sell
4,435
-146
-3% -$58.7K 0.01% 201
2020
Q2
$1.78M Buy
4,581
+775
+20% +$290K 0.01% 189
2020
Q1
$1.2M Sell
3,806
-301
-7% -$102K 0.01% 238
2019
Q4
$1.5M Buy
4,107
+621
+18% +$197K 0.01% 240
2019
Q3
$891K Buy
3,486
+106
+3% +$29.7K 0.01% 310
2019
Q2
$897K Sell
3,380
-44
-1% -$11.2K 0.01% 302
2019
Q1
$911K Sell
3,424
-657
-16% -$189K 0.01% 275
2018
Q4
$1.17M Buy
+4,081
New +$1.29M 0.01% 210

Other funds holding HUM

Wealthfront Advisers's HUM Position: Q1 2026 in Review

Wealthfront Advisers reduced its Humana (HUM) stake by 5.3% in Q1 2026, selling an estimated $66.2K and leaving 5,774 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #717.

Wealthfront Advisers first reported a position in HUM in Q4 2018 and has held it in 30 quarters since. The position peaked at $7.39M in Q4 2022. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Wealthfront Advisers held 5,774 shares of Humana worth $1M as of Q1 2026.
  • Wealthfront Advisers sold 323 Humana shares in Q1 2026, an estimated $66.2K.
  • Humana made up ﹤0.01% of Wealthfront Advisers's portfolio in Q1 2026, its #717 holding.
  • Wealthfront Advisers first reported a position in Humana in Q4 2018 and has held it in 30 quarters since.
  • Wealthfront Advisers's Humana position peaked at $7.39M in Q4 2022.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Wealthfront Advisers's 13F filing for Q1 2026, filed 5 May 2026.